About GANIC Pharmaceuticals
Based in New Jersey, GANIC Pharmaceuticals is a new specialty pharmaceutical company, founded by a highly seasoned group of senior executives with 65 years of collective experience in the pharmaceutical industry, in partnership with Warburg Pincus, a leading global private equity firm. The company is focused on building a fully-integrated pharmaceuticals enterprise focused on certain specialty areas.
About Warburg Pincus
Warburg Pincus has been a leading private equity investor since 1971.
The firm currently has more than $35 billion of assets under management.
Warburg Pincus' investments are focused on a range of sectors in North
America, Europe and Asia, including financial services, healthcare,
industrial, technology, media and telecommunications, energy, consumer and
retail and real estate. Since inception, the firm has raised 12 private
equity funds that have invested more than $31 billion in approximately 600
companies in more than 30 countries. The firm has invested $6.6 billion in
healthcare-related companies around the world, including approximately $1.6
billion to help build nearly 40 biotechnology and pharmaceutical companies.
The firm has an active global portfolio of more than 125 companies and
offices in Beijing, Frankfurt, Hong Kong, London, Mumbai, New York, San
Francisco, Shanghai and Tokyo. For more information, visit
Todd Fogarty or Joseph Kuo
Kekst and Company
|SOURCE GANIC Pharmaceuticals|
Copyright©2008 PR Newswire.
All rights reserved